virus

U of M COVID-19 Clinical Trial Expands Participant Enrollment Opportunities

This trial is testing hydroxychloroquine, an FDA-approved medicine for the prevention and treatment of malaria. This is the first clinical trial to determine if hydroxychloroquine is effective in preventing COVID-19 in humans.

Other News

cat
A study conducted by the UMN College of Veterinary Medicine found that household cats were more susceptible than dogs to natural infection…
person with COVID symptoms
As the first trial of its kind, researchers will use common and widely available drugs to treat symptoms of COVID-19. This story was…
SeroNet COVID-19 Vaccine Response Study screenshot
The University of Minnesota is leading a research study that aims to better understand the immune system’s response to COVID-19 vaccines.…